Together, these pathways recapitulate the stromal and immune features validated in the imaging dataset, indicating that SERPINB3 may function as a molecular bridge connecting tumor-intrinsic programs with stromal reprogramming and immune suppression. The gene discussed is SERPINB3; the disease is neoplasm.